These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28091558)

  • 21. Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.
    Sommerer C; Zeier M; Morath C; Reiser J; Scharnagl H; Stojakovic T; Delgado GE; März W; Kleber ME
    Sci Rep; 2019 Jan; 9(1):475. PubMed ID: 30679668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus.
    Feng G; Gao JL; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C
    Acta Diabetol; 2017 Nov; 54(11):1047-1055. PubMed ID: 28894973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes.
    Chuengsamarn S; Rattanamongkolgul S; Jirawatnotai S
    J Diabetes Complications; 2014; 28(2):124-9. PubMed ID: 24412514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy.
    Lupușoru G; Ailincăi I; Sorohan BM; Andronesi A; Achim C; Micu G; Caragheorgheopol A; Manda D; Lupușoru M; Ismail G
    Diabetes Res Clin Pract; 2021 Dec; 182():109116. PubMed ID: 34728182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
    Engström G; Zöller B; Svensson PJ; Melander O; Persson M
    Thromb Haemost; 2016 Mar; 115(3):657-62. PubMed ID: 26466866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
    Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
    Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.
    Borné Y; Persson M; Melander O; Smith JG; Engström G
    Eur J Heart Fail; 2014 Apr; 16(4):377-83. PubMed ID: 24464777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.
    Meijers B; Poesen R; Claes K; Dietrich R; Bammens B; Sprangers B; Naesens M; Storr M; Kuypers D; Evenepoel P
    Kidney Int; 2015 Jan; 87(1):210-6. PubMed ID: 24897037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
    Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
    J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes.
    Bardini G; Innocenti M; Rotella CM; Giannini S; Mannucci E
    J Clin Lipidol; 2016; 10(1):109-15. PubMed ID: 26892127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
    Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
    Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.
    Guo SM; Han M; Chen MX; Ning Y; Pei GC; Li YQ; Dai W; Ge SW; Deng YJ; Guo YY; Li XQ; Haller H; Xu G; Rong S
    PLoS One; 2015; 10(9):e0138718. PubMed ID: 26380984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum ferritin and microalbuminuria in Type 2 diabetes in Taiwan.
    Hsu YH; Huang MC; Chang HY; Shin SJ; Wahlqvist ML; Chang YL; Hsu KC; Hsu CC
    Diabet Med; 2013 Nov; 30(11):1367-73. PubMed ID: 23756251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
    Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
    Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
    Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
    J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability.
    Olson FJ; Thurison T; Ryndel M; Høyer-Hansen G; Fagerberg B
    Clin Biochem; 2010 Jan; 43(1-2):124-30. PubMed ID: 19822140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.